Skip to main content
PREDILIFE logo

PREDILIFE — Investor Relations & Filings

Ticker · ALPRE ISIN · FR0010169920 LEI · 9695006IK5NBKHQU9116 PA Human health and social work activities
Open in API
Filings indexed 150 across all filing types
Latest filing 2022-10-26 Earnings Release
Country FR France
Listing PA ALPRE

About PREDILIFE

https://www.predilife.com/en/

PREDILIFE specializes in predictive medicine, developing solutions to assess an individual's risk of developing major diseases. The company's approach integrates medical data, such as genetic testing and imaging, with artificial intelligence and mathematical models to create personalized risk profiles. Its primary offerings are predictive health check-ups, including a specialized test for assessing the 5-year risk of breast cancer (MammoRisk®) and a multi-condition check-up that evaluates the risk for several common cancers (lung, prostate, colorectal, melanoma) and cardiovascular disease. Based on these risk profiles, PREDILIFE provides personalized follow-up and preventive recommendations. The company offers its end-to-end solution, which includes remote consultations, to businesses, insurers, and healthcare professionals to facilitate wider access to preventive care.

Recent filings

Filing Released Lang Actions
RÉSULTATS SEMESTRIELS 2022 : MULTIPLICATION DE LA VENTE DES BILANS PRÉDICTIFS À DES ENTREPRISES AUX SECTEURS D'ACTIVITÉ DIVERSIFIÉS
Earnings Release Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE" and announces "RÉSULTATS SEMESTRIELS 2022" (Half-Year Results 2022). It provides selected financial information for the period ending June 30, 2022, including revenue, operating result, and net result, comparing them to the previous year. This content strongly indicates a release of periodic financial results. The definition for Interim / Quarterly Report (IR) is 'Comprehensive financial report for a period shorter than a year (e.g., half-year)'. Although this is a press release announcing the results, the core content is the summary of the half-year financial performance, making it an Interim Report (IR) summary, rather than just an Earnings Release (ER) which is typically just key highlights, or an RPA which only announces the publication date of the full report (though it does mention the full report will be published later, the current document contains the actual summarized results). Given the detailed financial table and management commentary on the half-year performance, IR is the most appropriate classification. H2 2022
2022-10-26 French
MARIONNAUD RENOUVELLE L'OFFRE DE BILANS PRÉDICTIFS DU CANCER DU SEIN AUPRÈS DE SES SALARIÉES SUITE AU SUCCÈS DE LA PREMIÈRE OPÉRATION - UN NOUVEAU FRUIT DU PARTENARIAT MERCER PREDILIFE
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'COMMUNIQUÉ DE PRESSE' (Press Release) dated October 25, 2022. It announces a business update regarding the renewal of a partnership between Marionnaud, Mercer, and PREDILIFE concerning predictive health screenings. This type of announcement, detailing a specific business event or partnership update rather than comprehensive financial results (10-K, IR, ER) or a formal regulatory filing, best fits the category for general regulatory announcements or miscellaneous corporate news that doesn't fit a more specific code. Since it is a press release announcing a business development, and not a formal financial report, it falls under the general regulatory/announcement category. Given the options, 'RNS' (Regulatory Filings - general regulatory announcements and fallback category) is the most appropriate fit for a standard press release detailing a corporate partnership update.
2022-10-25 French
LE GROUPE TF1 S'ENGAGE POUR LA SANTÉ DE SES COLLABORATEURS EN PROPOSANT UN BILAN PRÉDICTIF A TOUS SES SALARIÉS DE 40 A 50 ANS
Regulatory Filings Classification · 1% confidence The document is a press release dated October 20, 2022, announcing a commercial partnership between PREDILIFE and the TF1 Group regarding predictive health assessments for TF1 employees. This is an announcement about a business development, partnership, and a service offering, not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It does not fit the specific definitions for AGM-R, AR, MANG, CT, CAP, DVA, DLST, DIRS, SR, XLSX, FS, CGR, IRAT, IP, LTR, TAR, MRQ, MDA, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Since it is a general corporate announcement that doesn't fit a more specific category, the most appropriate fallback is Regulatory Filings (RNS), which serves as a general category for miscellaneous announcements.
2022-10-20 French
TRIPLEMENT DU CHIFFRE D'AFFAIRES AU 1ER SEMESTRE 2022
Earnings Release Classification · 1% confidence The document is a press release dated August 30, 2022, announcing the company's revenue (chiffre d'affaires) for the first half of 2022 (1er semestre 2022). It provides key financial highlights (revenue figures, growth rate) but is not the comprehensive, audited annual report (10-K) or the detailed interim report (IR). This format, focusing on key results immediately following the reporting period, aligns perfectly with an Earnings Release (ER). The document is short and focuses on results, not announcing the publication of a larger report. H1 2022
2022-08-30 French
BILAN SEMESTRIEL AU 30 JUIN 2022 DU CONTRAT DE LIQUIDITE PREDILIFE - CONTRACTÉ AVEC TSAF - TRADITIONS SECURITIES AND FUTURES
Capital/Financing Update Classification · 1% confidence The document is titled "BILAN SEMESTRIEL AU 30 JUIN 2022 DU CONTRAT DE LIQUIDITE PREDILIFE" (Semi-annual balance sheet as of June 30, 2022, for the PREDILIFE liquidity contract). It details the status of a liquidity contract, including the number of shares and cash held at the beginning and end of the period (31/12/2021 vs 30/06/2022), and a detailed log of transactions (purchases and sales) executed under this contract during the first half of 2022. This type of report, focusing on the execution and status of a liquidity agreement, is a specific regulatory disclosure. It is not a full Annual Report (10-K), an Earnings Release (ER), or a standard Interim Report (IR), which focus on the company's overall financial performance. It is a specific disclosure related to market making/liquidity provision. Among the provided codes, 'DIRS' (Director's Dealing) is for insider trades, 'POS' (Transaction in Own Shares) is for buybacks/issuance, and 'CAP' (Financing Update) is too broad. Since this is a specific report detailing the activity of a liquidity contract, which often falls under market surveillance or specific regulatory requirements related to share trading transparency, it most closely aligns with disclosures related to share transactions or specific regulatory filings. Given the options, and recognizing this as a periodic report on market activity related to the company's shares under a formal agreement, it is a specialized filing. It is not a standard financial report (IR, 10-K) or a management discussion (MDA). It is a specific regulatory disclosure concerning share activity, but not director dealing. Since there is no explicit 'Liquidity Contract Report' code, and it details share transactions under a formal arrangement, it is best classified as a specialized regulatory filing. However, looking closely at the content, it is a periodic report (semestriel/half-yearly) detailing share activity, which is often required for listed companies. If we must choose from the list, and recognizing it is a formal, periodic report detailing share movement under a specific agreement, it is a specialized disclosure. Given the options, and the focus on share transactions, it is closest to a specialized regulatory filing. Since it is a formal, periodic report detailing share activity under a contract, it fits best under the general 'Regulatory Filings' (RNS) if no better fit exists, or potentially 'Transaction in Own Shares' (POS) if the liquidity contract is viewed as a form of share management, but POS usually refers to formal buyback programs. Given the context of a formal, periodic report on liquidity provider activity, RNS (Regulatory Filings) is the most appropriate fallback for a specialized, non-standard report type.
2022-07-19 French
SUCCES DE L'OFFRE AU PUBLIC D'OBLIGATIONS CONVERTIBLES
Capital/Financing Update Classification · 1% confidence The document is a press release dated July 11, 2022, announcing the successful subscription results of a public offering of convertible bonds ('OCEANE'). It details the amount raised (€1.755 million), the intended use of proceeds (financing deployment of predictive health assessments), and provides detailed dilution calculations based on the potential conversion of these bonds into shares. This content directly relates to fundraising, capital structure changes, and the issuance of new securities (convertible debt). This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific financing event.
2022-07-11 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.